Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 124

Results For "Customer"

1248 News Found

Aceto acquires specialty exipients company A&C
News | April 16, 2021

Aceto acquires specialty exipients company A&C

Acquisition of A&C expands Aceto’s Western manufacturing footprint


Aurore to merge with Solara in an all-stock transaction
News | April 10, 2021

Aurore to merge with Solara in an all-stock transaction

The merger is in line with Solara’s strategy of accelerating growth via appropriate inorganic actions


Tatva Chintan Pharma Chem plans for IPO files DRHP with SEBI
News | April 05, 2021

Tatva Chintan Pharma Chem plans for IPO files DRHP with SEBI

TCPCL is the largest and only commercial manufacturer of SDAs for zeolites in India


Lonza completes divestment of two sites to NextPharma
News | April 02, 2021

Lonza completes divestment of two sites to NextPharma

Strategic divestment of Ploermel and Edinburgh sites will enable NextPharma to benefit from operational synergies and optimize existing expertise and technologies


Piramal Pharma to acquire 100% stake in Hemmo for Rs 775 Cr
News | April 01, 2021

Piramal Pharma to acquire 100% stake in Hemmo for Rs 775 Cr

This acquisition marks PPS’ foray into the development and manufacturing of peptide APIs


Merck accelerates expansion plans for single-use products critical to manufacturing vaccines
News | March 18, 2021

Merck accelerates expansion plans for single-use products critical to manufacturing vaccines

The company will add a single-use assembly production unit at its Life Science Center in Molsheim, France.


LifeClean and Lonza Specialty Ingredients sign distribution agreement for disinfectants
News | March 17, 2021

LifeClean and Lonza Specialty Ingredients sign distribution agreement for disinfectants

Lonza Specialty Ingredients has become LifeClean’s first strategic industrial partner.


Pharma sector will be $130 billion strong by 2030: EY-FICCI paper
News | March 04, 2021

Pharma sector will be $130 billion strong by 2030: EY-FICCI paper

The Indian pharma industry has grown at a compounded growth rate of ~11% in the domestic market and ~16% in exports over the last two decades


DSM secures victory in patent infringement litigation against Anhui Tiger
News | March 02, 2021

DSM secures victory in patent infringement litigation against Anhui Tiger

Tiger can no longer make an important biotin intermediate using a DSM patented process.


Accelerated growth in pharma depends on the right policies: Experts
News | March 01, 2021

Accelerated growth in pharma depends on the right policies: Experts

A mix of favorable government policies and a positive environment will create a win-win situation for all stakeholders